AVEA raised €2.4M in a funding round in Jun 2022. The company is based in Zug, Switzerland. Investors in the round: Longevity Co-Investment Fund, Maximon, The Longevity Company Builder. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
